CureVac NV sues BioNTech for IP infringementGerman mRNA vaccine developer CureVac, whose COVID-19 vaccine was not effective, on Monday sued BioNTech/Pfizer for infringement of four patents. more ➔
French Ipsen falls after Epizyme take-over announcementShares of French drugmaker Ipsen fell by 4.4% at Euronext Paris after the company announced to take over US cancer specialist Epizyme Inc. for $247m. more ➔
TWB announces winners in industrial biotech start-up contestAt the end of the TWB Start-up day, which was attended by more than 200 biotech professionals, two industrial biotechnology companies were awarded prizes worth €50,000. more ➔
BIONTech breaks ground for manufacturing site in RwandaBioNTech SE has announced it is going to ship the first containers for mRNA malaria vaccine production from this year’s end toKigall. more ➔
Cannabis players Canify AS and Bavaria Weed merge to form Canify AGIn an effort to become a major player in Europe’s growing pharmaceutical-grade cannabis market, Danish Canify AS and Bavaria Weed GmbH merge to form Canify AG. more ➔
Unilever launches $120m venture with GenomaticaUnder the $120m deal, Genomatica and Unilever will scale plant- and waste-based alternative to palm oil and fossil fuels. more ➔
Roche obtains special authorisation for bispecific antibodyRoche obtained from European Medicine Agency (EMA) a special authorization (conditional approval) for new bispecific antibody Lunsumio for treatment of relapsed or refractory follicular (R/R) lymphoma … more ➔
Andera Partners, Imcheck therapeutics, Kurma, marseille, Pfizer, wellington French ImCheck get´s a USD103m check by Pfizer and a pack of VCs ImCheck Therapeutics located in Marseille, France, announced today the close of a EUR 96 million (USD 103 million) financing, co-led by Earlybird and Andera Partners. Kurma Partners, Eurazeo, Gimv, … more ➔
$50m for London CHARM Therapeutics for deep minded folding expertise CHARM Therapeutics launches with a $50 million Series A financing to transform structure-based drug discovery using its proprietary DragonFold AI technology. more ➔
Biotalys’ first proteinbased biocontrol shows up in vineyards Based on data from the latest trials in grapes across vineyards in diverse climates throughout California and New York, Biotalys’ biocontrol product Evoca provided superior preventative control of Botrytis … more ➔
